| PERIOD ENDING | 31-Jan-09 | 31-Jan-08 | 31-Jan-07 | | Total Revenue | 10,406 | 28,443 | 33,383 | | Cost of Revenue | 7,276 | 9,893 | 14,050 | | | Gross Profit | 3,130 | 18,550 | 19,333 | | | Operating Expenses | | Research Development | 1,430 | 4,394 | 6,706 | | Selling General and Administrative | 8,825 | 9,811 | 9,786 | | Non Recurring | (29,592) |
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 22,467 | 4,345 | 2,841 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,076 | 833 | 468 | | Earnings Before Interest And Taxes | 23,543 | 5,178 | 3,309 | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | 23,543 | 5,178 | 3,309 | | Income Tax Expense | 5,924 | (4,969) | 23 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 17,619 | 10,147 | 3,286 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 17,619 | 10,147 | 3,286 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $17,619 | $10,147 | $3,286 |
|
0.24% Nasdaq 
Income Statement
